X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (45719) 45719
Book Chapter (296) 296
Dissertation (208) 208
Government Document (55) 55
Publication (54) 54
Conference Proceeding (35) 35
Magazine Article (32) 32
Newspaper Article (15) 15
Web Resource (13) 13
Book / eBook (8) 8
Streaming Video (2) 2
Book Review (1) 1
Journal / eJournal (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (25657) 25657
c-myc (18744) 18744
animals (16967) 16967
oncology (12217) 12217
mice (10316) 10316
expression (9582) 9582
biochemistry & molecular biology (9393) 9393
cell biology (9241) 9241
cancer (8085) 8085
female (7629) 7629
apoptosis (7260) 7260
male (6636) 6636
gene expression (6530) 6530
proto-oncogene proteins c-myc - metabolism (6287) 6287
proto-oncogene proteins c-myc - genetics (5852) 5852
myc (5848) 5848
cell line, tumor (5217) 5217
genes, myc (5038) 5038
proteins (4802) 4802
myc protein (4326) 4326
cell proliferation (4032) 4032
gene expression regulation, neoplastic (3865) 3865
signal transduction (3839) 3839
tumors (3820) 3820
gene (3716) 3716
molecular sequence data (3573) 3573
base sequence (3566) 3566
cell cycle (3546) 3546
research (3529) 3529
activation (3491) 3491
genetics & heredity (3462) 3462
cell line (3431) 3431
gene-expression (3427) 3427
tumor cells, cultured (3394) 3394
genes (3291) 3291
differentiation (3094) 3094
protein (3066) 3066
genetic aspects (3053) 3053
transcription (3025) 3025
cells (3021) 3021
prognosis (2980) 2980
growth (2949) 2949
middle aged (2928) 2928
proliferation (2911) 2911
phosphorylation (2889) 2889
mutation (2864) 2864
analysis (2673) 2673
rats (2665) 2665
multidisciplinary sciences (2629) 2629
cells, cultured (2587) 2587
transfection (2566) 2566
adult (2558) 2558
immunohistochemistry (2545) 2545
hematology (2471) 2471
research article (2439) 2439
c-myc protein (2417) 2417
transcription factors (2339) 2339
aged (2329) 2329
dna (2319) 2319
rna, messenger - genetics (2312) 2312
transcription, genetic (2288) 2288
n-myc (2252) 2252
rna, messenger - metabolism (2136) 2136
gene expression regulation (2127) 2127
oncogenes (2120) 2120
p53 (2052) 2052
down-regulation (2041) 2041
biology (2035) 2035
gene amplification (2006) 2006
transcription factors - metabolism (1998) 1998
neuroblastoma (1995) 1995
inhibition (1990) 1990
apoptosis - drug effects (1987) 1987
promoter regions, genetic (1981) 1981
stem cells (1954) 1954
pathology (1921) 1921
kinases (1883) 1883
physiological aspects (1845) 1845
identification (1827) 1827
medicine, research & experimental (1827) 1827
cell differentiation (1819) 1819
metastasis (1815) 1815
cell growth (1783) 1783
dna-binding proteins - metabolism (1707) 1707
mice, transgenic (1701) 1701
health aspects (1698) 1698
transcription factors - genetics (1694) 1694
messenger-rna (1680) 1680
genes, myc - genetics (1679) 1679
rna (1676) 1676
breast cancer (1673) 1673
proto-oncogene proteins - genetics (1662) 1662
protein binding (1648) 1648
reverse transcriptase polymerase chain reaction (1638) 1638
amino acid sequence (1631) 1631
blotting, western (1627) 1627
in-vivo (1611) 1611
dna-binding proteins - genetics (1587) 1587
medicine (1581) 1581
leukemia (1565) 1565
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (44426) 44426
Chinese (1706) 1706
Japanese (372) 372
French (181) 181
German (107) 107
Russian (82) 82
Portuguese (52) 52
Korean (38) 38
Spanish (37) 37
Polish (23) 23
Italian (15) 15
Czech (12) 12
Norwegian (9) 9
Dutch (8) 8
Hungarian (5) 5
Turkish (5) 5
Swedish (4) 4
Persian (3) 3
Bosnian (2) 2
Latin (2) 2
Serbian (2) 2
Catalan (1) 1
Croatian (1) 1
Hebrew (1) 1
Romanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2006, 1. Aufl., Current topics in microbiology and immunology, ISBN 9783540239680, Volume 302., vii, 282
The Myc/Mad/Mad network is defined by, and functions through, the interactions between individual Myc and Mad family proteins with Max as well as by... 
Myc oncogenes | Myc proteins | Oncogenes | Human genetics | Human Genetics | Medical Microbiology | Biomedicine
Book
Science translational medicine, ISSN 1946-6242, 2019, Volume 11, Issue 484, p. eaar5012
Inhibiting MYC has long been considered unfeasible, although its key role in human cancers makes it a desirable target for therapeutic intervention. One reason... 
MEDICINE, RESEARCH & EXPERIMENTAL | LUNG-CANCER | DNA-BINDING | INHIBITION | PEPTIDES | PROTEIN | MAX | C-MYC | N-MYC | EXPRESSION | TUMOR INITIATION | CELL BIOLOGY | Lung Neoplasms - drug therapy | Basic-Leucine Zipper Transcription Factors - metabolism | Proto-Oncogene Proteins c-myc - therapeutic use | Adenocarcinoma of Lung - pathology | Humans | Cell-Penetrating Peptides - pharmacokinetics | Lung Neoplasms - pathology | Peptide Fragments - pharmacology | Promoter Regions, Genetic - genetics | Proto-Oncogene Proteins c-myc - administration & dosage | Cell-Penetrating Peptides - pharmacology | Cell-Penetrating Peptides - therapeutic use | Protein Binding - drug effects | Adenocarcinoma of Lung - drug therapy | Female | Proto-Oncogene Proteins c-myc - pharmacology | Disease Models, Animal | Carcinoma, Non-Small-Cell Lung - pathology | Mice, Inbred C57BL | Peptide Fragments - administration & dosage | Peptide Fragments - pharmacokinetics | DNA - metabolism | E-Box Elements - genetics | Proto-Oncogene Proteins c-myc - metabolism | Proto-Oncogene Proteins c-myc - pharmacokinetics | Animals | Proto-Oncogene Proteins c-myc - antagonists & inhibitors | Cell Line, Tumor | Peptide Fragments - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Protein Multimerization - drug effects | Cell culture | Animal models | Side effects | Myc protein | Small cell lung carcinoma | Transcription
Journal Article
Cell death and differentiation, ISSN 1350-9047, 2013, Volume 20, Issue 3, pp. 503 - 514
Journal Article
Oncogene, ISSN 1476-5594, 2018, Volume 38, Issue 1, pp. 140 - 150
Overexpression of MYC oncogene is highly prevalent in many malignancies such as aggressive triple-negative breast cancers (TNBCs) and it is associated with... 
ACTIVATION | PROTEIN | EFFICACY | MAX | BIOCHEMISTRY & MOLECULAR BIOLOGY | C-MYC | CHEMOTHERAPY | CELL BIOLOGY | ONCOLOGY | OMOMYC | GENETICS & HEREDITY | RESISTANCE | BET BROMODOMAIN INHIBITORS | TRANSCRIPTION FACTOR | Proto-Oncogene Proteins c-myc - therapeutic use | Humans | Recombinant Fusion Proteins - therapeutic use | Neoplasm Proteins - antagonists & inhibitors | Genes, myc | Peptide Library | Triple Negative Breast Neoplasms - drug therapy | Proto-Oncogene Proteins c-myc - administration & dosage | Cell-Penetrating Peptides - pharmacology | Cell-Penetrating Peptides - therapeutic use | Protein Engineering | Inhibitory Concentration 50 | Female | Peptide Fragments - genetics | Molecular Targeted Therapy - methods | Recombinant Fusion Proteins - administration & dosage | Amino Acid Sequence | Peptide Fragments - administration & dosage | Peptide Fragments - pharmacokinetics | Models, Molecular | Proto-Oncogene Proteins c-myc - pharmacokinetics | Leucine Zippers - genetics | Drug Synergism | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Recombinant Fusion Proteins - pharmacokinetics | Proto-Oncogene Proteins c-myc - antagonists & inhibitors | Cell Line, Tumor | Protein Conformation | Mice | Peptide Fragments - therapeutic use | Proto-Oncogene Proteins c-myc - genetics | Cell-Penetrating Peptides - administration & dosage | Mutation | Drug Resistance, Neoplasm - drug effects | Drug Screening Assays, Antitumor | Gene expression | Health aspects | Oncogenes | Bone grafts | Chemotherapy | Peptides | Transcription | Breast cancer | Myc protein | Fusion protein | Protein structure | Apoptosis | Brief Communication
Journal Article
Nature genetics, ISSN 1546-1718, 2018, Volume 50, Issue 4, pp. 515 - 523
Journal Article